Cargando…
The role of Tau protein in resistance to paclitaxel
Resistance to taxanes, related to limited efficacy of systemic therapy in cancer patients, is multifactorial. Among mechanisms of resistance to taxanes, those related to microtubule-associated proteins (MAP), including protein Tau, are of great importance. Protein Tau (50–64 kD) binds to beta-tubuli...
Autores principales: | Smoter, Marta, Bodnar, Lubomir, Duchnowska, Renata, Stec, Rafał, Grala, Bartłomiej, Szczylik, Cezary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162141/ https://www.ncbi.nlm.nih.gov/pubmed/21713447 http://dx.doi.org/10.1007/s00280-011-1696-7 |
Ejemplares similares
-
Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
por: Smoter, Marta, et al.
Publicado: (2013) -
Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
por: Stec, Rafał, et al.
Publicado: (2009) -
Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018) -
Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013) -
K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
por: Stec, Rafał, et al.
Publicado: (2012)